184 related articles for article (PubMed ID: 2376048)
1. Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon alpha in a murine hepatic metastasis model.
Arroyo PJ; Bash JA; Wallack MK
Cancer Immunol Immunother; 1990; 31(5):305-11. PubMed ID: 2376048
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma.
Tanaka N; Sivanandham M; Wallack MK
J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):283-93. PubMed ID: 7881637
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model.
Sivanandham M; Scoggin SD; Tanaka N; Wallack MK
Cancer Immunol Immunother; 1994 Apr; 38(4):259-64. PubMed ID: 8168121
[TBL] [Abstract][Full Text] [Related]
4. Vaccinia colon oncolysate immunotherapy for murine hepatic metastases can be modulated with low-dose interleukin-2. Third place winner: Conrad Jobst Award.
Barnavon Y; Iwaki H; Bash JA; Wallack MK
Am Surg; 1988 Dec; 54(12):696-701. PubMed ID: 3264127
[TBL] [Abstract][Full Text] [Related]
5. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model.
Jack AM; Aydin N; Montenegro G; Alam K; Wallack M
J Surg Res; 2007 May; 139(2):164-9. PubMed ID: 17275030
[TBL] [Abstract][Full Text] [Related]
6. Treatment of murine hepatic metastases with vaccinia colon oncolysates and IL-2.
Barnavon Y; Iwaki H; Bash JA; Brettschneider F; Hilsenbeck S; Darnell E; Wallack MK
J Surg Res; 1988 Dec; 45(6):523-30. PubMed ID: 3263545
[TBL] [Abstract][Full Text] [Related]
7. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.
McLaughlin JP; Schlom J; Kantor JA; Greiner JW
Cancer Res; 1996 May; 56(10):2361-7. PubMed ID: 8625312
[TBL] [Abstract][Full Text] [Related]
8. Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice.
McIntosh JK; Mulé JJ; Krosnick JA; Rosenberg SA
Cancer Res; 1989 Mar; 49(6):1408-14. PubMed ID: 2784349
[TBL] [Abstract][Full Text] [Related]
9. Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
Shinohara H; Killion JJ; Kuniyasu H; Kumar R; Fidler IJ
Clin Cancer Res; 1998 Sep; 4(9):2053-63. PubMed ID: 9748119
[TBL] [Abstract][Full Text] [Related]
10. Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice.
Sivanandham M; Shaw P; Bernik SF; Paoletti E; Wallack MK
Cancer Immunol Immunother; 1998 Jul; 46(5):261-7. PubMed ID: 9690454
[TBL] [Abstract][Full Text] [Related]
11. Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.
Gazit Z; Weiss DW; Shouval D; Yechezkeli M; Schirrmacher V; Notter M; Walter J; Kedar E
Cancer Immunol Immunother; 1992; 35(2):135-44. PubMed ID: 1596937
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
[TBL] [Abstract][Full Text] [Related]
13. Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma.
Hirschowitz EA; Naama HA; Evoy D; Lieberman MD; Daly J; Crystal RG
Cancer Gene Ther; 1999; 6(6):491-8. PubMed ID: 10608345
[TBL] [Abstract][Full Text] [Related]
14. Vaccinia virus-infected C-C36 colon tumor cell lysates stimulate cellular responses in vitro and protect syngeneic Balb/c mice from tumor cell challenge.
Iwaki H; Barnavon Y; Bash JA; Wallack MK
J Surg Oncol; 1989 Feb; 40(2):90-6. PubMed ID: 2915544
[TBL] [Abstract][Full Text] [Related]
15. Establishment of combined immuno-chemotherapy with systemically administered gemcitabine and intra-portal administration of interleukin-2 in murine models of liver metastases of pancreatic cancer.
Ito Y; Aiura K; Ueda M; Kitajima M; Kitagawa Y
Int J Oncol; 2008 Jul; 33(1):49-58. PubMed ID: 18575750
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy in liver tumors: II. Intratumoral injection with activated tumor-infiltrating lymphocytes, intrasplenic administration of recombinant interleukin-2 and interferon alpha causes tumor regression and lysis.
Liu DL; Håkansson CH; Seifert J
Cancer Lett; 1994 Sep; 85(1):39-46. PubMed ID: 7923100
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy in liver tumors: III. A new experimental model of metastatic liver tumors from colorectal carcinoma for cytokine therapy.
Liu DL; Radnell M; Svanberg K; Seifert J
Cancer Lett; 1995 Jan; 88(2):211-19. PubMed ID: 7874695
[TBL] [Abstract][Full Text] [Related]
18. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.
Rao JB; Chamberlain RS; Bronte V; Carroll MW; Irvine KR; Moss B; Rosenberg SA; Restifo NP
J Immunol; 1996 May; 156(9):3357-65. PubMed ID: 8617961
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antiproliferative effect of the combination of natural human tumor necrosis factor-alpha and natural murine interferon-alpha/beta against colon-26 adenocarcinoma hepatic metastases in a murine model.
Sanada E; Fuchimoto S; Orita K
Acta Med Okayama; 1990 Aug; 44(4):217-22. PubMed ID: 2244476
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
